Drug manufacturers have increased their production, and some such as Novo Nordisk have asked the FDA to ban further production of compounded versions of their drugs. If that happens, Lavin says many ...

Novo Nordisk has launched its weight-loss drug Wegovy in China after it was approved by local health authorities in June. It ...

NASH drug Rezdiffra exceeded all expectations in the recent quarterly earnings release. The stock rose more than 50% in a few days – and the company now has a market cap of close to $8 billion.

As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

The drugs include Mounjaro, also known as tirzepatide, and semaglutide, which is sold under the brand names Wegovy, Ozempic ...

What’s unique about GLP-1s—a.k.a. Ozempic, Monjauro, Wegovy, and Zepbound, among others—is that they target hormones, which play a major role in your weight and weight loss, says Dr. Russo. These ...

“But the widespread use for weight-loss drugs mimicking the FDA-approved versions has ... mpox in a traveler You will likely ...

Ozempic, Wegovy and Mounjaro are often the most popular weight loss drugs. While these medications help people lose weight, they have undesirable side effects. Now, scientists at the University of ...

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

"Over 50% of my patients on semaglutide and tirzepatide have remarkably less desire to drink alcohol." Decotiis also ...

Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...